S ince Riientgen's discovery of x-rays, crystallography has been the method of choice to determine molecular structure (1, 2). The utility of this technique toward proteins was f i i demonstrated in 1960 with the determination of the myoglobin structure (3) and has since been applied to much more complex macromolecular structures and assemblies, such as viruses (4, 5), membrane proteins (6), and the ribosome (7,8). The gradual accumulation of structures has allowed a more complete representation of three-dimensional (3D) protein folds, enabling more successful homology modeling of unknown structures (9). Breakthroughs in genome sequencing projects have underscored the need for concomitant advances in structural biology if we hope to determine the extent of protein folding-space and elucidate how an assembly of proteins constitutes a cellular organism. As a result, structural genornics programs have sprung up both nationally and internationally, with significant funding from the National Institutes of Health in the United States (www.nigms.nih.gov).Determining protein structures on a genome-wide scale is a formidable task. Traditionally, each target gene is cloned into an expression vector, expressed with the use of a single set of conditions, and the resulting protein is then purified. With this protein in hand, a number of basic screens for crystallization are used, followed by further screening, if necessary, to optimize crystal quality. Lastly, the best crystal(s) are used for diffraction analysis. Such isolated investigations on individual proteins are being replaced with parallel sample processing approaches for structure determination in both the public and private sectors. Public efforts, at least in the United States, are being directed toward elucidating the universe of protein structural families. In the private sector, structural data are also being harnessed for biochemical function prediction and as initial 3D templates in drug discovery programs.Using conventional methods, the throughput of rnacromolecular 3D structure determination can be improved only by increasing the person-hours of work. As a consequence, academic and industrybased researchers have initiated research and development progmns to develop high-throughput (HT) structure determination process pipelines, as diagrammed in the figure. The stage is now being set for the industrialization of structural biology in much the same way that Henry Ford revolutionized the auto industry. Structures will no longer be determined one at a time. "Assembly line" structure determination approaches are being developed that can cope with HT. Large multiinstitutional conglomerates of expertise have coalesced into factorylike consortiums to provide the wide range of methodologies needed to convert gene sequences into validated protein structures.HT structural biology requires development of methods and reagents to streamline and automate the process of protein structure determination. Given the large number of gene sequences, their protein products, and co...